BUSINESSThe Marijuana Herald
Mile High Labs files FDA drug master file for CBD isolate
Colorado-based Mile High Labs filed a Type II Drug Master File for its 98% CBD isolate, enabling pharmaceutical developers to reference confidential manufacturing and quality information in their own FDA submissions. The filing is not FDA approval, but it shows a regulatory pathway Oklahoma cannabinoid manufacturers may need to evaluate when supplying pharmaceutical programs.
Published Nov 20, 2026
Read the full article at The Marijuana Herald#national#colorado#hemp#compliance#manufacturing#pharmaceuticals
Read the original source
Leafy summaries provide industry context. Confirm details with The Marijuana Herald.